AstraZeneca PLC Sponsored ADR
Head Quarters
1 Francis Crick Avenue Cambridge Biomedical Campus USWebsite
http://www.astrazeneca.comIndustry
PharmaceuticalsMajorEmployees
59700Exchange
New York Stock Exchange, Inc.AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 0156, medi 573, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on April 6, 1999 and is headquartered in London, the United Kingdom.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 0 |
| Gross Margin (%) | 0.83% |
| Net Margin (%) | 0.02% |
| Returns | Stock |
| Sales | $20.87B |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | $127.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 33.57 |
| EPS | $1.00 |